The goals for the Clinical Characterization and Biorepository Core (CCBC) include the following:
- Provide Clinical Research Support to JCIs, Scholars, and ORDRCC investigators requiring assistance with regulatory requirements, protocol development, and development of a Clinical Research Unit (CRU) for support with clinical specifics.
- Maximize use of the OMRF CAP-Approved Biorepository to support rheumatic disease research by providing biobanking SOPs and infrastructure, oversight and management of current collections, as well as expansion of new collections, and enhance current collections by providing longitudinal data, patient reported outcomes, and real-time monitoring.
- Apply Translational Clinical Research Informatics to optimize usefulness of paired clinical and experimental data to address critical rheumatic disease questions and training session/ workshops to familiarize ORDRCC investigators with these resources.
- Enable subsetting of the active patients in our cohorts by integrating classification of subjects based on molecular phenotypes and molecular profiles in order to reduce heterogeneity of rheumatic disease